Federated Hermes
TXG icon

Federated Hermes’s 10x Genomics TXG Stock Holding History

Federated Hermes’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.59M Sell
250,121
-361,493
-59% -$9.47M 0.01% 702
2026
Q1 		$13M Sell
611,614
-33,294
-5% -$666K 0.02% 569
2025
Q4 		$10.5M Sell
644,908
-6,457
-1% -$97.5K 0.02% 601
2025
Q3 		$7.61M Sell
651,365
-136,157
-17% -$1.78M 0.01% 635
2025
Q2 		$9.12M Buy
787,522
+684,659
+666% +$6.24M 0.02% 593
2025
Q1 		$898K Buy
+102,863
New +$1.3M ﹤0.01% 1136
2024
Q3 		– Sell
-7,000
Closed -$136K – 2166
2024
Q2 		$136K Buy
+7,000
New +$183K ﹤0.01% 1534
2023
Q4 		– Sell
-9,045
Closed -$373K – 2214
2023
Q3 		$373K Hold
9,045
– – ﹤0.01% 1414
2023
Q2 		$505K Sell
9,045
-1,586
-15% -$85.8K ﹤0.01% 1369
2023
Q1 		$593K Sell
10,631
-15,147
-59% -$707K ﹤0.01% 1352
2022
Q4 		$939K Sell
25,778
-221,750
-90% -$7.25M ﹤0.01% 1153
2022
Q3 		$7.05M Buy
247,528
+136,295
+123% +$5.19M 0.02% 608
2022
Q2 		$5.03M Buy
111,233
+111,201
+347,503% +$5.77M 0.01% 681
2022
Q1 		$2K Buy
+32
New +$2.8K ﹤0.01% 2038
2021
Q1 		– Sell
-50,662
Closed -$7.17M – 2349
2020
Q4 		$7.17M Buy
50,662
+40,618
+404% +$5.89M 0.01% 717
2020
Q3 		$1.25M Buy
+10,044
New +$1.05M ﹤0.01% 1164

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federated Hermes's TXG Position: Q2 2026 in Review

Federated Hermes reduced its 10x Genomics (TXG) stake by 59% in Q2 2026, selling an estimated $9.47M and leaving 250,121 shares worth $9.59M. The position accounts for 0.01% of the portfolio, ranked #702.

Federated Hermes first reported a position in TXG in Q3 2020 and has held it in 16 quarters since. The position peaked at $13M in Q1 2026. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Federated Hermes held 250,121 shares of 10x Genomics worth $9.59M as of Q2 2026.
  • Federated Hermes sold 361,493 10x Genomics shares in Q2 2026, an estimated $9.47M.
  • 10x Genomics made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #702 holding.
  • Federated Hermes first reported a position in 10x Genomics in Q3 2020 and has held it in 16 quarters since.
  • Federated Hermes's 10x Genomics position peaked at $13M in Q1 2026.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.